Clinical Trials Browser

Phase 2/3 × Neuroblastoma × alectinib × Clear all

NCT05770037 2025-11-24

DETERMINE

CNSGenitourinaryLymphoidOther hematologic neoplasm

Carcinoma, Renal Cell, Lymphoma, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neuroblastoma, Lymphoma, Large-Cell, Anaplastic, Hematologic Neoplasms